Hologic wins patent case ruling, trial date set
Diagnostic, medical imaging and surgical products developer Hologic Inc. of Bedford (Nasdaq: HOLX) said Thursday [1] that a U.S. District Court in California has denied Becton, Dickison and Company’s (NYSE: BDX) request to dismiss patent infringment claims brought against it by Gen-Probe, a Hologic subsidiary.